US-based medical technology company Advita Ortho has announced the first clinical use of its next-generation knee replacement platform in Japan, marking a significant milestone in advancing personalised joint replacement procedures.
The platform combines Activit-E polyethylene technology in the Truliant knee system with the latest version of Advita GPS surgical navigation and Newton balancing intelligence.
Dr. Hiroshi Watanabe performed the initial procedures at the Tokorozawa Hakushokai Hospital in Japan.
Commenting on the technology, Watanabe said, “Every patient presents a unique combination of anatomy, soft-tissue characteristics and functional expectations. Having real-time information about alignment and balance throughout the procedure helps me make more informed decisions and tailor the surgery to each patient.”
Aurelio Sahagun, CEO of Advita Ortho, added, “These first cases demonstrate how advanced implant materials, surgeon-controlled guidance and dynamic balancing intelligence can work together in a unified workflow to provide surgeons with actionable information throughout the procedure and support an efficient, personalized approach to knee replacement.”
He added that Japan has consistently been an early adopter of innovations that advance patient care.
At the core of the platform is Activit-E polyethylene technology – a highly crosslinked vitamin E-stabilized bearing material developed through years of materials science research. The material is designed to deliver low wear while maintaining the strength and toughness required for knee replacement.
When combined with Advita’s GPS navigation and Newton balancing intelligence, the platform provides real-time feedback during total knee replacement surgery, enabling surgeons to assess alignment, soft-tissue balance and other key factors before final implantation.
Following the launch in Japan, Advita plans to introduce the platform across additional global markets.
